Kanzler CEO and co-founder has more than 30 years experience in the process- and business development in the biotech industry. Since 2007 he is serving as Management Consultant for production and technology-development for biotech- and pharma-industry, specified for strategic and economic issues. Between 1993 and 2007 he was a department head at Boehringer Ingelheim Austria, responsible for the economic issues of the industrial biopharmaceutical business. Prior to this, he was head of process development for biopharmaceutical processes at Boehringer Ingelheim Austria (1981-1993). Otto Kanzler is a serial entrepreneur having founded and co-founded several companies, all of which are still active - CEO / CFO of Remute Bio GmbH (founded 2016), co-founder and interim CEO / CFO of Phoenestra GmbH (founded 2015), Advisor of directions GmbH (since 2015), co-founder and CEO of Syconium Lactic Acid GmbH (founded 2014), co-founder and CFO of TAmiRNA GmbH (founded 2012), co-founder and CEO of Evercyte GmbH und Chorus GmbH, (both founded 2011).
Pediatric Neurology & Diseases, Pediatric Cardiology, Pediatric Care